Official Publication of the Society for Laboratory Automation and Screening
This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Advertisement


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit February 7, 2018

SLAS.org    SLAS2018    Moving? New job? Let SLAS know.      

Advertisement

Advertisement

Advertisement








 

Advertisement

news

Announcing the 2018 SLAS Journal Achievement Award Honorees
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS Discovery and SLAS Technology celebrate honorees in three categories — Readers Choice, Authors Choice and Reviewer Excellence. The 2018 SLAS Journal Achievement Awards reflect popularity of published articles with readers and authors throughout 2017 and exceptional volunteer service in 2017.

All articles are now freely available at SLAS Discovery Online and SLAS Technology Online.
More


Advertisement


Welcome to New SLAS President Sabeth Verpoorte
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS welcomes Sabeth Verpoorte, who began her term as SLAS president at SLAS2018 in San Diego, CA. "As I begin my term as SLAS President, I want to assure you that the Board and Professional Team are committed to serving your evolving needs as life sciences professionals," said Verpoorte. "While we are pleased with our current programming and services, we feel that SLAS can be even more valuable to you in the years to come. Please know that we are wholly committed to providing you the information, education and connections you need to distinguish yourself in an ever-changing field." Verpoorte welcomes three new members to the SLAS Board of Directors at SLAS2018 — Emilio Diez Monedero, Peter Simpson and SeverineTamas-Lhoustau — and thanked outgoing members Scott Atkin, Michele Cleary and Susan Lunte. She looks forward to serving the SLAS global community in her new role. More


Special Issue Call for Papers: Academic Screening Centers Showcase
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS Discovery Associate Editor Marc Bickle of the Technology Development Studio of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany seeks original research papers, technical notes and reviews that focus on science in the context of academic screening endeavors. An in-depth editorial will describe each laboratory and its operational model. More


Advertisement
Sponsored Content


2018 SLAS Europe Conference and Exhibition: Transforming Research
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Register now for the inaugural 2018 SLAS Europe Conference and Exhibition, June 27-29, 2018, in Brussels, Belgium. Early bird registration rates save participants €140 and expire on Friday, March 30.

Scientific tracks for this premier event for the European life sciences discovery and technology community include:

  • Emerging Investigative Biology — examining topics such as Biological Mechanisms Involved in Aging and Degenerative Disease, Exploring Target Biology and The Impact of New Technologies on the Treatment of Rare Diseases;

  • Technology — focusing on subject matter such as Organoids and Other Complex Biological Systems in Drug Discovery and Development, Revolutions in Phenotypic Screening for Modern-Day Drug Discovery and Next Generation Analytics; and

  • Discovery — investigating areas such as Bringing Biology and Technology Together to Enable the Early Drug Discovery Pipeline, Future SAR Screening and Late-Stage Discovery.

  • The conference also includes poster presentations focusing on thought-provoking research and a multinational exhibition and sessions that explore opportunities in business and technology careers.
    More


    Collaborative Sparks Fly in SLAS Ignite Academic Theater!
    SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Six selected researchers tapped into the experience, insights and capabilities of peers and complementary organizations via the SLAS Ignite Academic Theater, an accelerant for collaborative partnerships and contract relations. The inaugural class of speakers offered 10-minute presentations followed by Q&A as they discussed topics from mass spectroscopy and disulfide trapping to identifying new drug targets, combinatorial drug discovery and high-content screening. More




    Advertisement
    Essential Steps to Better Collaboration

    Because drug discovery involves scientists from multiple disciplines and often organizations, it is critical to have an efficient mechanism for researchers to collaborate and realize the collective value of their specialized knowledge, assets, and capabilities. This free white paper details the essential keys to effective collaboration.


    SLAS2018 in San Diego Ends Today
    SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    The Feb. 3-7 event attracted life sciences discovery and technology professionals from all around the globe. With 144 podium sessions, 230-plus poster presentations and 300-plus multinational exhibitors, in addition to Short Courses, Exhibitor Tutorials, Special Interest Group meetings, career services, SLAS author services and a memorable Tuesday Evening Celebration in Old Town San Diego, the SLAS International Conference and Exhibition set a new bar of science education excellence. Watch SLAS Social Media — SLAS Facebook, SLAS Twitter and SLAS LinkedIn — for photos from the event as well as announcement of the 2018 SLAS Innovation Award winner named in today's closing keynote presentation. Mark your calendar now for SLAS2019, Feb. 2-6, Washington, DC. More


    5 Good Reasons Your Employer Should Reward You for Publishing in the SLAS Journals
    SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
    SLAS Technology (Translating Life Sciences Innovation) and SLAS Discovery (Advancing Life Sciences R&D) offer essential ways to navigate the ever-increasing volume of peer-reviewed research for life sciences discovery and technology professionals. Visit these rich resources regularly to:

    1. Find answers, ideas and inspiration by searching the scientific archives of SLAS Technology, SLAS Discovery and other SAGE journals with keywords and author names. Save searches and/or sign up to receive custom search alerts via e-mail.

    2. Sign up for citation tracking alerts.

    3. Sign up to be alerted when new reports publish online ahead-of-print.

    4. See what's trending in the Most Read and Most Cited monitors.

    5. Get to know the people behind the science by listening to the SLAS Technology Podcast Series.

    NEW: Meet Elodie Sollier-Christen of Vortex Biosciences, the latest interview in the podcast series, as she talks about the groundbreaking technology that earned her the 2017 SLAS Innovation Award. MORE SLAS Technology / MORE SLAS Discovery




    Advertisement
    AMRI'S DISCOVERY SOLUTIONS DRIVE INNOVATION
    AMRI’s integrated drug discovery centers of excellence combine scientific expertise and leading-edge technology to accelerate innovation. Our complete suite of solutions includes comprehensive discovery biology, synthetic and medicinal chemistry, DMPK and bioanalytical services for successful hit-to-lead-to-candidate selection.

    Contact us to put our Discovery expertise to work for you, contact: Customerservice@amriglobal.com.

    news


    You Can Teach an Old Drug New Tricks
    Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    This ERBB4 receptor, a member of the receptor tyrosine kinase family, is of increasing interest for science and medicine. Mutations in ERBB4 have been linked in recent studies to melanoma and lung cancer, and altered expression of ERBB4 has been observed in breast cancer, neuroblastoma, colon cancer, and non-small cell lung cancer, though the receptor has not received sufficient study to date. More


    Alarm Sounds for Gene Therapy Toxicity, But Was the Concern Legitimate?
    Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    A controversial new study by veteran gene therapy scientist James Wilson at the University of Pennsylvania is rousing concerns about the safety of high-dose gene therapy trials. It disclosed that a therapy designed to treat a muscle-wasting disease called spinal muscular atrophy given to monkeys and piglets resulted in severe toxicity in the animals, which had to be euthanized. More




    Advertisement
    Explore the Latest Festo Innovations

    Join Festo as we kick off the new year at SLAS in San Diego, CA. Discover our latest products and innovative technologies for laboratory automation at booth 637. Stop by and speak with our experts to help find a solution for your laboratory challenges.


    Scientists Develop New Chemical Tool to Study RNA Structures Inside Cells
    Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    University of California, Irvine scientists have created a new chemical tool that can analyze RNA structures within living cells. The technique could facilitate a better grasp of how RNA structures fold and form in cells, as well as help in the design of drugs targeting RNA. Researchers describe their study results in an advance online publication on the Nature Chemical Biology website. More


    One-Shot Multiple Borylation toward BN-Doped Nanographenes
    Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    One-shot double, triple, and quadruple borylation reactions of triarylamines were developed through a judicious choice of boron source and Brønsted base. With the aid of borylation reactions, a variety of BN-doped nanographenes were synthesized in two steps from commercially available starting materials. An organic light-emitting diode device employing BN-doped nanographene as an emitter exhibited deep pure-blue emission at 460 nm, with CIE coordinates of (0.13, 0.11), and an external quantum efficiency of 18.3%. More




    Scientists Identify Fleeting Quantum Jitters that Drive Mutation Rate in DNA
    Genetic Engineering & Bioctechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Scientists in the U.S. have described how the DNA double helix contains an intrinsic timer that determines how often mutations might occur spontaneously. The team used a technique known as nuclear magnetic resonance relaxation dispersion to recognize how the bases in a double-stranded helix of DNA undergo fleeting changes in their shape — lasting just a thousandth of a second — which allow polymerase enzymes to insert the wrong base during DNA replication. More


    Researchers Develop Potential Blood Test for Alzheimer's Disease
    The Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Researchers in Japan and Australia have developed the first blood test to detect amyloid-β protein buildup in the brain, one of the earliest hallmarks of Alzheimer's disease. The findings, published in Nature, show that measurements of the protein and its precursors in the blood can predict neural amyloid-β deposition and could pave the way for a cheap and minimally invasive screening tool for the disease. More


    A 3-D Approach to Stop Cancer in Its Tracks
    Phys.org    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Every day, roughly 100 billion new cells are created inside the human body. These cells join trillions of older cells to form the tissues and organs we rely on to stay alive. Sometimes when a cell is created, a mutation occurs within its DNA, transforming the cell into something defective and potentially dangerous to the body's internal environment. Usually, a cell will recognize its own defects and quickly terminate itself. More


    Researchers Uncover Mechanism Behind Common Parkinson's Mutation
    Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Northwestern Medicine investigators have discovered how a gene mutation results in buildup of a toxic compound known to cause Parkinson's disease symptoms, defining for the first time the mechanism underlying that aspect of the disease. The study, published in Neuron, points to a potential novel therapeutic pathway using drugs originally intended to treat another condition, Gaucher's disease, according to senior author Joseph Mazzulli, PhD. More


    Career


    HTS Specialist
    St. Jude's Children’s Research Hospital
    US – TN – Memphis

    Assistant Professor, SHP
    MD Anderson Cancer Center
    US – TX – Houston

    Field Support Engineer – Midwest
    Labcyte, Inc.
    US – IL – Chicago

    Search Jobs at SLAS Career Connections


    news

     


    SLAS Point-to-Point
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Dennis Hall, Executive Editor, 469.420.2656   
    Contribute news

    This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

    SLAS Terms of Use Policy

    MultiView Privacy Policy 

    Recent issues

    Jan. 31, 2018
    Jan. 24, 2018
    Jan. 17, 2018
    Jan. 10, 2018






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063